CorrespondenceVedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease
Section snippets
Acknowledgments
The authors gratefully acknowledge the healthy controls and the patients with IBD involved in this study.
References (8)
Gastroenterology
(2016)Gastroenterology
(2016)Aliment Pharmacol Ther
(2016)Gut
(2017)
There are more references available in the full text version of this article.
Cited by (0)
This study was supported by unrestricted grants by the Colitis-Crohn Denmark and the A.P. Moeller Foundation of the Advancement of Medical Science.
Conflicts of interest The authors have made the following disclosures: MJ, JK, and DCB have received speaker’s fees from and/or served as scientific advisers to Takeda, the manufacturer of vedolizumab. The remaining authors disclose no conflicts. Takeda had no role in the design, collection of data, or interpretation of the results of this study.
Authors names in bold designate shared co-first authors.
© 2017 by the AGA Institute